Anamorelin · Performance
Anamorelin dosage by bodyweight
Reference dose ranges scaled across bodyweight bands, anchored to the most-cited research dose (100000 mcg @ 75 kg). Educational only — never a recommendation.
| Bodyweight band | Reference dose range | At U-100 (1 mg/mL) | Vol. on U-100 (5 mg / 2 mL) | 5× t½ elapsed |
|---|---|---|---|---|
| <60 kg / <132 lb | 62333–84333 mcg | 62.33–84.33 mL | 2493–3373 units24.93–33.73 mL | — |
| 60–75 kg / 132–165 lb | 76500–103500 mcg | 76.50–103.50 mL | 3060–4140 units30.60–41.40 mL | — |
| 75–90 kg / 165–198 lb | 93500–126500 mcg | 93.50–126.50 mL | 3740–5060 units37.40–50.60 mL | — |
| 90–105 kg / 198–231 lb | 110500–149500 mcg | 110.50–149.50 mL | 4420–5980 units44.20–59.80 mL | — |
| >105 kg / >231 lb | 127500–172500 mcg | 127.50–172.50 mL | 5100–6900 units51.00–69.00 mL | — |
Volume column assumes a standard 5 mg vial reconstituted with 2 mL bacteriostatic water (concentration 2.5 mg/mL); insulin units shown for a U-100 syringe. No published half-life on file for Anamorelin; the elapsed-time column is hidden.
Anamorelin by goal
Read Anamorelin's profile and dosing through a specific research-goal lens.
⚠
Educational use only
This calculator is provided for research and educational purposes. Outputs are derived from the values you enter. Always verify your math and consult a licensed physician before acting on any result.